| Affymax Announces Another Favorable Data Monitoring Committee ... - PR-Inside.com (Pressemitteilung) |
|
|
In the Phase 3 program, Hematide is being evaluated to treat anemia in chronic renal failure patients on dialysis and not on dialysis. ... |